ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2020 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI) has announced the schedule for its fourth quarter and fiscal year 2020 earnings release and conference call.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ICU Medical, Inc. (Nasdaq:ICUI) has announced the schedule for its fourth quarter and fiscal year 2020 earnings release and conference call. The earnings report will be released on February 25, 2021, at approximately 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET. Investors can access the call at (800) 936-9761 with conference ID 8029238 or via webcast on the company's website. ICU Medical specializes in innovative medical products for infusion therapy and critical care applications, helping to achieve clinical safety and workflow efficiency.
Details
News Market Reaction – ICUI
The recorded move for ICUI in the trading session of this news was +0.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN CLEMENTE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2020 earnings release and conference call.
The Company will release its fourth quarter and fiscal year 2020 results on Thursday, February 25th, 2021 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, February 25th, 2021. The call can be accessed at (800) 936-9761, conference ID 8029238. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.